-
Regen III Closes Final Tranche Of Oversubscribed Private Placement
25 Nov 2024 08:57 GMT
… OTCQB: ISRJF) (FSE: PN4) ( " ReGen III " or the … Property Office of Singapore (" IPOS ") for the method … .
Consultant
In addition to ReGen III's existing … corporate awareness initiatives.
About ReGen III
ReGen III is a cleantech …
-
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
15 Sep 2021 11:54 GMT
… 4 million additional doses of REGEN-COV.
New agreement for …
IPOs
Procept Biorobotics Corporation (NASDAQ: PRCT) priced its upsized initial public offering of … company, priced its upsized IPO of 10.8 million … disorders, priced its upsized IPO of 4.8 million …
-
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
16 Jun 2021 13:22 GMT
… trial found that adding investigational REGEN-COV to usual care reduced … full biologics license application for REGEN-COV this summer.
FDA Approves … : CNTG)
IPO
Swiss biopharma Molecular Partners AG priced its initial public offering of 3 …
-
The Alliance for Regenerative Medicine Announces 2016 Regen Med and Advanced Therapies State of the Industry Briefing
06 Jan 2016 17:17 GMT
WASHINGTON, DC -- (Marketwired) -- 01/06/16 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the gene therapy, cell therapy and tissue engineering sectors, announced its 2016 Regen Med & Advanced …
-
Intellicell Biosciences' Flagship Partner, Regen Medical, PC Has Passed QAAAA Office Based Surgery Inspection
13 Oct 2015 12:29 GMT
NEW YORK, NY -- (Marketwired) -- 10/13/15 -- IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company pioneering a new proprietary medical process that results in acquiring …
-
MCI Onehealth Reports Fiscal 2021 Financial Results
31 Mar 2022 21:26 GMT
… Health Technology revenue, respectively. Initial Public Offering on January 6, 2021 raised … out for investors during our initial public offering,” said Dr. Alexander Dobranowski, … future commercial partners, including: Regen Scientific Inc., a personalized, …